B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode. - Wikidata - wikimedia - TriplyDB

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.

http://www.wikidata.org/entity/Q35000296

about

Effects of Beta-Blocker Withdrawal in Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: meta-epidemiological survey The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Acute decompensated heart failure update.Effect of oral β-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study Beta-blocker therapy in unstable severe heart failure, evidence or experience?Causes and treatment of oedema in patients with heart failure.Medication management of chronic heart failure in older adults.Treatment of acute heart failure in the emergency department.Acute decompensated heart failure: evolving literature and implications for future practice.Recommendations on pre-hospital & early hospital management of acute heart failure: a consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Em Characteristics, Management, and Outcomes of Acute Heart Failure in the Emergency Department: A Multicenter Registry Study with 1-year Follow-up in a Chinese Cohort in Beijing.Non-withdrawal of beta blockers in acute decompensated chronic and de novo heart failure with reduced ejection fraction in a prospective multicentre study of patients with acute heart failure in the Middle East.Acute Decompensated Heart Failure.Dyspnoea in patients with acute heart failure: an analysis of its clinical course, determinants, and relationship to 60-day outcomes in the PROTECT pilot study.Initiation or maintenance of beta-blocker therapy in patients hospitalized for acute heart failure.BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.Association between hypo- and hyperkalemia and outcome in acute heart failure patients: the role of medications.Clinical tolerability of generic versus brand beta blockers in heart failure with reduced left ventricular ejection fraction: a retrospective cohort from heart failure clinic.Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure.Guideline-Directed Medical Therapy and Survival Following Hospitalization in Patients with Heart Failure.Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study.

P2860

Q26801321-0BE3957E-3023-496E-992F-0204EC65FB0A Q31043715-1016C70C-5EDB-4E96-B725-D9860173BC83 Q34522113-34F1D033-16F0-44CA-8CA5-8136CF8FCF74 Q35139964-EC9286C8-5D20-4427-A6A2-92BDDC447427 Q35561264-1059341C-182F-413A-AB19-85E206B50A4A Q36484589-954FCA88-506C-4CA1-AACA-D9AACB42D04E Q38074093-BFDB3DA5-896A-4890-8CDB-44A45F486729 Q38126374-0B26DD24-C452-4434-A938-2DF70A1B5753 Q38145265-5E02F4A5-6F85-48DA-BA5B-35D34E50B5D9 Q38161451-EE6DCAA9-B419-4E2A-962C-3E48B8535328 Q38496703-00EAEC68-6FF0-48B6-8BBE-0233DF7F832C Q38641541-A5F2BEE3-9821-477C-B1B9-50255EEC6032 Q38685401-5EFF29B4-8DEE-4AE3-9B9C-75B67B8EDFE2 Q38957219-0D7B94B9-8C59-4472-A50D-3DA7C27270E8 Q39289569-CCA06B23-151E-4689-A397-95AC70BBFC3D Q39800705-78282808-88B4-4484-A807-D4F2103AC033 Q40666750-596B3603-3D98-4F3E-9843-52D99EA59AE9 Q47696462-238C6C6B-E3E1-4533-B4A5-7A4982E067F7 Q49591511-28C48CFB-B394-46C8-99C5-FA28C70AAA17 Q50047461-73D98C39-F17D-492A-9649-372C3FB02F2E Q50103339-45110D55-A0D0-4F39-8CED-B7AA462C4C15 Q51756509-DE26FD97-C26A-4158-BFB1-9576312736BE Q53098624-F49815F6-CADE-439A-88DE-7629C9284C25

P2860

B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode.

http://www.wikidata.org/entity/Q35000296

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

B-CONVINCED: Beta-blocker CONt ...... for a decompensation episode.

@ast

B-CONVINCED: Beta-blocker CONt ...... for a decompensation episode.

@en

type

label

B-CONVINCED: Beta-blocker CONt ...... for a decompensation episode.

@ast

B-CONVINCED: Beta-blocker CONt ...... for a decompensation episode.

@en

prefLabel

B-CONVINCED: Beta-blocker CONt ...... for a decompensation episode.

@ast

B-CONVINCED: Beta-blocker CONt ...... for a decompensation episode.

@en

P1433

Q35000296-9EC5A8B4-030C-4DBC-B17E-74BEADBDE3D9

P1476

Q35000296-5C724A91-13C3-4097-9AC0-7045F95F8AEB

P2093

Q35000296-2B5185A9-9B40-45D7-A4C1-D5FE792C9B01

Q35000296-444C7504-1B05-4998-88DA-50B89092B83D

Q35000296-44BB26C5-1A6B-4F1F-B15D-F66F5A3376B4

Q35000296-4E979881-6D22-45A0-92C6-06B6E59FA403

Q35000296-580367DF-34B4-4228-A350-32E4807C9BE9

Q35000296-74831382-0240-439A-80CE-73102D8DF724

Q35000296-76B4289F-F8DA-43AF-874E-208CD44D45D7

Q35000296-8300D5BF-DF38-4969-9505-C1DFB6B4FE0E

Q35000296-87621FEB-D51E-4F90-9FC2-8C63BF0F00C8

Q35000296-A50C191A-715F-4350-B286-F33708198E7E

P2860

Q35000296-09CA68AA-9D95-4E8A-AD06-D27CDB7409E0

Q35000296-0E02BE5F-450B-44A3-ADB4-4C1364CB7963

Q35000296-1D0C2CFC-8401-48EE-9EBB-67685F1AAB59

Q35000296-23E18C81-69DB-41C7-ACFC-4D00F0D9E13B

Q35000296-46C40E96-5F55-42D0-9594-432BFEFD5BAE

Q35000296-57789CBA-C52D-4F05-8258-2657D969191D

Q35000296-658BA710-06BF-4D5D-9F12-EBDB6A20AA7F

Q35000296-705040AB-82E6-4EFE-A7E0-24A6DFB48741

Q35000296-82A43D5A-B484-46A2-ADA5-356865F6588D

Q35000296-8E0E9165-7CE2-4AAD-B41A-A2BC9B9435B2

P304

Q35000296-03E94386-6E8C-4720-8864-2C1EFF2310EA

P31

Q35000296-5D85F351-FC05-40BC-8781-8DBD65ACD5F8

P356

Q35000296-9FF4535A-7B2F-4A44-85D7-7A93F396A714

P433

Q35000296-320B47F2-3C94-4BD7-B94F-373291D66C53

P478

Q35000296-C922E1D0-522B-4D1B-81DF-29AD8164610E

P50

Q35000296-7C626B57-4A36-4D67-B40B-9DD80E113EFC

Q35000296-9A4B75C1-0BE1-465C-A960-39A1205A2F3B

P577

Q35000296-9EB88169-E1FB-4635-AB1E-0E1863E308F5

P5875

Q35000296-ACFE2FD0-2425-4CA7-857F-8CB760C99D6E

P698

Q35000296-06887335-388C-4D1F-A984-5877C7CA4D89

P921

Q35000296-D1CF7E0A-12CE-4C87-B233-9DD90C555345

P356

P1433

European Heart Journal

P1476

B-CONVINCED: Beta-blocker CONt ...... D for a decompensation episode

@en

P2093

Anissa Bouzamondo

http://www.w3.org/2001/XMLSchema#string

Arnaud Jegou

http://www.w3.org/2001/XMLSchema#string

B-CONVINCED Investigators

http://www.w3.org/2001/XMLSchema#string

Elodie Fauveau

http://www.w3.org/2001/XMLSchema#string

Fabrice Bauer

http://www.w3.org/2001/XMLSchema#string

Guillaume Jondeau

http://www.w3.org/2001/XMLSchema#string

Jean Noel Trochu

http://www.w3.org/2001/XMLSchema#string

Jean-Christophe Eicher

http://www.w3.org/2001/XMLSchema#string

Marie-Laure Tanguy

http://www.w3.org/2001/XMLSchema#string

Philippe Lechat

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

The EuroHeart Failure Survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian Survey on Acute Heart Failure.

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Beta-blocker use and outcomes among hospitalized heart failure patients.

P304

2186-2192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHP323

http://www.w3.org/2001/XMLSchema#string

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Jourdain

Michel Galinier

P577

2009-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26777619

http://www.w3.org/2001/XMLSchema#string

P698

19717851

http://www.w3.org/2001/XMLSchema#string

P921